Earth, TX, United States
Earth, TX, United States

Time filter

Source Type

Houston TX, Nov. 01, 2016 (GLOBE NEWSWIRE) -- RadioMedix Inc. (Houston TX) and AREVA Med (Plano TX) announced today that they have been awarded a collaborative Small Business Innovation Research (SBIR) Contract Grant by the National Institutes of Health, National Cancer Institute to evaluate targeted alpha-emitter therapy of neuroendocrine tumors (NETs). This is the fourth NIH grant awarded to RadioMedix during the last three years. Targeted Peptide Receptor Radio Therapy (PRRT) of NETs is one of the main clinical focuses of RadioMedix, which has long been involved in  several clinical studies as a co-sponsor or a collaborator. AREVA Med is focused on the production of lead-212 (212Pb), a rare metal used in TAT, and the development of therapeutics using this metal. “We have established a very good collaboration with AREVA Med and we are very pleased that this work resulted in the SBIR grant award,” said Izabela Tworowska PhD, Principal Investigator and RadioMedix Chief Science Officer.” We have got promising preliminary results and we are confident that this grant award will accelerate the development of Targeted Alpha Therapy (TAT) agents. I am grateful to NIH NCI agency for selecting this project for funding” “AREVA Med is very excited about its collaboration with RadioMedix  that will further support the growth of our pipeline of 212Pb-labeled agents, especially in NETs where we believe we can bring substantial additional efficacy compared to current treatment options” said Julien Torgue, PhD, AREVA Med Scientific Director. “We are confident that we have secured all resources needed to accelerate translation of targeted alpha therapy agents to clinic,” said Dr. Ebrahim Delpassand, CEO and Chairman of RadioMedix. “Our patients are anxiously waiting for this treatment, and we expect to launch a first in human clinical trial by the end of 2017.” Neuroendocrine tumors (NETs) are a heterogeneous group of rare neoplasms that originate from neuroendocrine cells. These neoplasms occur mostly in the gastrointestinal tract and pancreas, but can also occur in other tissues including thymus, lung, and other uncommon sites such as ovaries, heart and ear. Most NETs strongly express somatostatin receptors (SSTRs), predominantly of the SSTR2 subtype, providing the basis of antisecretory and antiproliferative therapy with somatostatin agonists (SSA), such as octreotide or lanreotide. Peptide receptor radiotherapy (PRRT), using therapeutically radiolabeled SSTR receptor ligands, directed against SSTRs has shown highly promising outcomes, even in patients with advanced disease. More about RadioMedix Inc. RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radiopharmaceuticals based on Gallium-68 chemistry for PET imaging and therapeutic (Alpha and Beta) radiopharmaceuticals for targeted radionuclide therapy in cancer. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for human clinical trials and probe development and small animal Molecular Imaging Facility for evaluation of agents in animal models. More information at http://radiomedix.com. AREVA Med is the AREVA Group medical subsidiary formed in 2009 to develop new therapies to fight cancer.  AREVA Med has developed a unique process to extract lead-212 (212Pb), a rare metal used in targeted alpha therapy (TAT), a novel approach which targets and destroys cancer cells, while limiting the impact on nearby healthy cells.  AREVA Med collaborates with world-renowned scientific partners, and formed a strategic global alliance with Roche in 2012, to create a new advanced alpha radioimmunotherapy platform. More information at http://arevamed.com.  Follow @AREVAmed on Twitter.


Houston TX, Nov. 01, 2016 (GLOBE NEWSWIRE) -- RadioMedix Inc. (Houston TX) and AREVA Med (Plano TX) announced today that they have been awarded a collaborative Small Business Innovation Research (SBIR) Contract Grant by the National Institutes of Health, National Cancer Institute to evaluate targeted alpha-emitter therapy of neuroendocrine tumors (NETs). This is the fourth NIH grant awarded to RadioMedix during the last three years. Targeted Peptide Receptor Radio Therapy (PRRT) of NETs is one of the main clinical focuses of RadioMedix, which has long been involved in  several clinical studies as a co-sponsor or a collaborator. AREVA Med is focused on the production of lead-212 (212Pb), a rare metal used in TAT, and the development of therapeutics using this metal. “We have established a very good collaboration with AREVA Med and we are very pleased that this work resulted in the SBIR grant award,” said Izabela Tworowska PhD, Principal Investigator and RadioMedix Chief Science Officer.” We have got promising preliminary results and we are confident that this grant award will accelerate the development of Targeted Alpha Therapy (TAT) agents. I am grateful to NIH NCI agency for selecting this project for funding” “AREVA Med is very excited about its collaboration with RadioMedix  that will further support the growth of our pipeline of 212Pb-labeled agents, especially in NETs where we believe we can bring substantial additional efficacy compared to current treatment options” said Julien Torgue, PhD, AREVA Med Scientific Director. “We are confident that we have secured all resources needed to accelerate translation of targeted alpha therapy agents to clinic,” said Dr. Ebrahim Delpassand, CEO and Chairman of RadioMedix. “Our patients are anxiously waiting for this treatment, and we expect to launch a first in human clinical trial by the end of 2017.” Neuroendocrine tumors (NETs) are a heterogeneous group of rare neoplasms that originate from neuroendocrine cells. These neoplasms occur mostly in the gastrointestinal tract and pancreas, but can also occur in other tissues including thymus, lung, and other uncommon sites such as ovaries, heart and ear. Most NETs strongly express somatostatin receptors (SSTRs), predominantly of the SSTR2 subtype, providing the basis of antisecretory and antiproliferative therapy with somatostatin agonists (SSA), such as octreotide or lanreotide. Peptide receptor radiotherapy (PRRT), using therapeutically radiolabeled SSTR receptor ligands, directed against SSTRs has shown highly promising outcomes, even in patients with advanced disease. More about RadioMedix Inc. RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radiopharmaceuticals based on Gallium-68 chemistry for PET imaging and therapeutic (Alpha and Beta) radiopharmaceuticals for targeted radionuclide therapy in cancer. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for human clinical trials and probe development and small animal Molecular Imaging Facility for evaluation of agents in animal models. More information at http://radiomedix.com. AREVA Med is the AREVA Group medical subsidiary formed in 2009 to develop new therapies to fight cancer.  AREVA Med has developed a unique process to extract lead-212 (212Pb), a rare metal used in targeted alpha therapy (TAT), a novel approach which targets and destroys cancer cells, while limiting the impact on nearby healthy cells.  AREVA Med collaborates with world-renowned scientific partners, and formed a strategic global alliance with Roche in 2012, to create a new advanced alpha radioimmunotherapy platform. More information at http://arevamed.com.  Follow @AREVAmed on Twitter.


Spine Injury Solutions, Inc. (SPIN) unveils well-received Affiliate Expansion Program at seminar in Atlanta. After three years in development, SPIN’s patented Quad Video HALO™ (QVH) Video Medical Records Technology (VMRT), paired with its successful seven year history of injury case financing delivered through three contracted “Affiliates”, the stage has now been set for a nationwide expansion of its unique new Affiliate Program adding a high-tech advantage to injured accident victims. HOUSTON, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, finance,  and healthcare solution company servicing the multi-billion dollar spine injury sector, through its Chairman/CEO Dr. William Donovan, MD is pleased to report that the Company’s attendance and speaker participation at the pre-announced James J. Mathis “Personal Injury: Understanding Colossus Seminar” in Atlanta, GA, February 11, 2017 was a success in several aspects. The Seminar attendees, primarily made up of healthcare providers and attorneys servicing the  Personal Injury (PI) industry were introduced (most for the first time), to SPIN’s proprietary, patented, Quad Video HALO™ v3.0 and its success in facilitating patient confidence, “Best Medical Practices” and higher case settlements in shorter time for cases involving diagnostic and treatment injections. The original beta QVH first began clinic testing and trials in 2014 in Houston TX with Northshore Orthopedics (NSO), SPIN’s first “Affiliate” owned by SPIN Founder/Chairman. NSO along with several satellite locations, using SPIN’s Medical Lien financing program since 2010, had, up until the first use of QVH in 2014, financed over 6,000 diagnostic injection procedures in the conventional non-technical way similar to what the rest of the country uses today. While under continuing testing and development, the QVH received its US Patent in 2015 and its successful completion of compliance testing of the Quad Video HALO System to meet EN 60601-1 safety standard for medical equipment along with its EU approval to carry the CE Mark, in 2016. SPIN has internally invested approximately $2.5 million in developing the QVH which has now been used and proven successful in an additional 2,400 case procedures. Early on in the testing of the QVH, second and third SPIN Affiliates were added in Midland/Odessa and Tyler, TX who contributed to the latter 2,400 procedures. Armed with data and both medical and attorney testimonials giving clear “Proof of Concept” to the conjoining of the QVH v3.0 with conventional spine injection procedures, SPIN management made the decision in late 2016, to develop a new  Nationwide all-encompassing affiliate program to be introduced for the first time at the Atlanta seminar. New SPIN affiliates once qualified and accepted, will be trained to provide best practices, be referred cases generated by SPIN paid-for marketing, and trained in the use of SPIN’s QVH, all provided at no additional cost to their existing practices.  Once the procedures are completed, SPIN will early monetize the affiliates case billing leaving no further collection risk. The new affiliate program capitalizes on SPIN’s unique position in having exclusive access to its patented QVH. When the decision was made in December to expand its affiliate program, the targets were to add a minimum of four affiliates, with two in Atlanta and maximum of 10 affiliates over the following year.  The company is pleased to report significant interest in the program by over 20 attendees, mostly from Atlanta, but also from four additional States making the high end of the target range appear very achievable. Additionally –though the QVH was originally developed for internal SPIN affiliate use, while under continuing development, it was  realized that a large additional market existed. A market for instantly transportable High Definition video providing transparency could be much broader.  For example, there is a need for  a Hybrid Video Integration Platform for general surgery, not only for QVH’s own four camera video showing internal x-ray real-time view along with three external cameras, but also to piggy-back additional video devices. QVH also has built-in capabilities to plug-in any digital or analog video medical device with “video out” capabilities. Devices used in robotic, arthroscopic, microscopic, etc. surgical procedures both for risk management, or use in hospitals and cadaver labs for global education can work with the QVH. Though direct sales were not the primary target at the Atlanta seminar, management also reports significant third party, non-PI interest, in the QVH such as described above from three attendees. Dr. Donovan stated; “On behalf of the SPIN and QVH Management, Directors and Development team, I cannot overstate how pleased we were with the reception we received from not just the attendees, but even the Sponsors and other Presenters at Atlanta. We anticipate adding and announcing new team members shortly. “ Donovan added; “For those not familiar with SPIN’s history, it should be noted that since inception some seven years ago, SPIN’s business advances to include the QVH development have been financed through its own organic revenues, sporadic third party straight debt paid off on time and some early loans by me later exchanged for shares. SPIN has never asked for, or received any outside equity financing, public or private. While I am the largest shareholder of the Company, the vast majority of my shares were either purchased in the open market or early loans I made to the Company which I converted to restricted shares at market value. The majority by far of my share purchases and/or debt conversions were at prices higher than the current share price.” We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons, DOs and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our management and financing services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases. Additional information about the company, along with a video can be found at its website at www.spineinjurysolutions.com. A wholly owned subsidiary of Spine Injury Solutions, Inc., Quad Video HALO, Inc brings surgeons and interventional pain management providers the ability to bring modern video documentation technology into the operating/treatment rooms. The Quad Video Technology™ V3.0 and HALO Rx™ creates a digital turnkey video and audio documentation solutions that integrates multiple views from other OR/treatment imaging sources with several other viewpoints just outside the sterile field. Additional information about QVH can be found at its website: www.quadvideohalo.com. Forward-Looking Statements: This press release includes forward-looking statements as determined by the U.S. Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical facts, included in this press release that address activities, events, or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations, healthcare services demands, changes in healthcare practices, government regulation, and other factors over which the company has little or no control. The company does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the warnings and cautionary statements contained in the company's recent filings with the SEC.


Spine Injury Solutions, Inc. (SPIN) unveils well-received Affiliate Expansion Program at seminar in Atlanta. After three years in development, SPIN’s patented Quad Video HALO™ (QVH) Video Medical Records Technology (VMRT), paired with its successful seven year history of injury case financing delivered through three contracted “Affiliates”, the stage has now been set for a nationwide expansion of its unique new Affiliate Program adding a high-tech advantage to injured accident victims. HOUSTON, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, finance,  and healthcare solution company servicing the multi-billion dollar spine injury sector, through its Chairman/CEO Dr. William Donovan, MD is pleased to report that the Company’s attendance and speaker participation at the pre-announced James J. Mathis “Personal Injury: Understanding Colossus Seminar” in Atlanta, GA, February 11, 2017 was a success in several aspects. The Seminar attendees, primarily made up of healthcare providers and attorneys servicing the  Personal Injury (PI) industry were introduced (most for the first time), to SPIN’s proprietary, patented, Quad Video HALO™ v3.0 and its success in facilitating patient confidence, “Best Medical Practices” and higher case settlements in shorter time for cases involving diagnostic and treatment injections. The original beta QVH first began clinic testing and trials in 2014 in Houston TX with Northshore Orthopedics (NSO), SPIN’s first “Affiliate” owned by SPIN Founder/Chairman. NSO along with several satellite locations, using SPIN’s Medical Lien financing program since 2010, had, up until the first use of QVH in 2014, financed over 6,000 diagnostic injection procedures in the conventional non-technical way similar to what the rest of the country uses today. While under continuing testing and development, the QVH received its US Patent in 2015 and its successful completion of compliance testing of the Quad Video HALO System to meet EN 60601-1 safety standard for medical equipment along with its EU approval to carry the CE Mark, in 2016. SPIN has internally invested approximately $2.5 million in developing the QVH which has now been used and proven successful in an additional 2,400 case procedures. Early on in the testing of the QVH, second and third SPIN Affiliates were added in Midland/Odessa and Tyler, TX who contributed to the latter 2,400 procedures. Armed with data and both medical and attorney testimonials giving clear “Proof of Concept” to the conjoining of the QVH v3.0 with conventional spine injection procedures, SPIN management made the decision in late 2016, to develop a new  Nationwide all-encompassing affiliate program to be introduced for the first time at the Atlanta seminar. New SPIN affiliates once qualified and accepted, will be trained to provide best practices, be referred cases generated by SPIN paid-for marketing, and trained in the use of SPIN’s QVH, all provided at no additional cost to their existing practices.  Once the procedures are completed, SPIN will early monetize the affiliates case billing leaving no further collection risk. The new affiliate program capitalizes on SPIN’s unique position in having exclusive access to its patented QVH. When the decision was made in December to expand its affiliate program, the targets were to add a minimum of four affiliates, with two in Atlanta and maximum of 10 affiliates over the following year.  The company is pleased to report significant interest in the program by over 20 attendees, mostly from Atlanta, but also from four additional States making the high end of the target range appear very achievable. Additionally –though the QVH was originally developed for internal SPIN affiliate use, while under continuing development, it was  realized that a large additional market existed. A market for instantly transportable High Definition video providing transparency could be much broader.  For example, there is a need for  a Hybrid Video Integration Platform for general surgery, not only for QVH’s own four camera video showing internal x-ray real-time view along with three external cameras, but also to piggy-back additional video devices. QVH also has built-in capabilities to plug-in any digital or analog video medical device with “video out” capabilities. Devices used in robotic, arthroscopic, microscopic, etc. surgical procedures both for risk management, or use in hospitals and cadaver labs for global education can work with the QVH. Though direct sales were not the primary target at the Atlanta seminar, management also reports significant third party, non-PI interest, in the QVH such as described above from three attendees. Dr. Donovan stated; “On behalf of the SPIN and QVH Management, Directors and Development team, I cannot overstate how pleased we were with the reception we received from not just the attendees, but even the Sponsors and other Presenters at Atlanta. We anticipate adding and announcing new team members shortly. “ Donovan added; “For those not familiar with SPIN’s history, it should be noted that since inception some seven years ago, SPIN’s business advances to include the QVH development have been financed through its own organic revenues, sporadic third party straight debt paid off on time and some early loans by me later exchanged for shares. SPIN has never asked for, or received any outside equity financing, public or private. While I am the largest shareholder of the Company, the vast majority of my shares were either purchased in the open market or early loans I made to the Company which I converted to restricted shares at market value. The majority by far of my share purchases and/or debt conversions were at prices higher than the current share price.” We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons, DOs and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our management and financing services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases. Additional information about the company, along with a video can be found at its website at www.spineinjurysolutions.com. A wholly owned subsidiary of Spine Injury Solutions, Inc., Quad Video HALO, Inc brings surgeons and interventional pain management providers the ability to bring modern video documentation technology into the operating/treatment rooms. The Quad Video Technology™ V3.0 and HALO Rx™ creates a digital turnkey video and audio documentation solutions that integrates multiple views from other OR/treatment imaging sources with several other viewpoints just outside the sterile field. Additional information about QVH can be found at its website: www.quadvideohalo.com. Forward-Looking Statements: This press release includes forward-looking statements as determined by the U.S. Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical facts, included in this press release that address activities, events, or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations, healthcare services demands, changes in healthcare practices, government regulation, and other factors over which the company has little or no control. The company does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the warnings and cautionary statements contained in the company's recent filings with the SEC.


Spine Injury Solutions, Inc. (SPIN) unveils well-received Affiliate Expansion Program at seminar in Atlanta. After three years in development, SPIN’s patented Quad Video HALO™ (QVH) Video Medical Records Technology (VMRT), paired with its successful seven year history of injury case financing delivered through three contracted “Affiliates”, the stage has now been set for a nationwide expansion of its unique new Affiliate Program adding a high-tech advantage to injured accident victims. HOUSTON, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, finance,  and healthcare solution company servicing the multi-billion dollar spine injury sector, through its Chairman/CEO Dr. William Donovan, MD is pleased to report that the Company’s attendance and speaker participation at the pre-announced James J. Mathis “Personal Injury: Understanding Colossus Seminar” in Atlanta, GA, February 11, 2017 was a success in several aspects. The Seminar attendees, primarily made up of healthcare providers and attorneys servicing the  Personal Injury (PI) industry were introduced (most for the first time), to SPIN’s proprietary, patented, Quad Video HALO™ v3.0 and its success in facilitating patient confidence, “Best Medical Practices” and higher case settlements in shorter time for cases involving diagnostic and treatment injections. The original beta QVH first began clinic testing and trials in 2014 in Houston TX with Northshore Orthopedics (NSO), SPIN’s first “Affiliate” owned by SPIN Founder/Chairman. NSO along with several satellite locations, using SPIN’s Medical Lien financing program since 2010, had, up until the first use of QVH in 2014, financed over 6,000 diagnostic injection procedures in the conventional non-technical way similar to what the rest of the country uses today. While under continuing testing and development, the QVH received its US Patent in 2015 and its successful completion of compliance testing of the Quad Video HALO System to meet EN 60601-1 safety standard for medical equipment along with its EU approval to carry the CE Mark, in 2016. SPIN has internally invested approximately $2.5 million in developing the QVH which has now been used and proven successful in an additional 2,400 case procedures. Early on in the testing of the QVH, second and third SPIN Affiliates were added in Midland/Odessa and Tyler, TX who contributed to the latter 2,400 procedures. Armed with data and both medical and attorney testimonials giving clear “Proof of Concept” to the conjoining of the QVH v3.0 with conventional spine injection procedures, SPIN management made the decision in late 2016, to develop a new  Nationwide all-encompassing affiliate program to be introduced for the first time at the Atlanta seminar. New SPIN affiliates once qualified and accepted, will be trained to provide best practices, be referred cases generated by SPIN paid-for marketing, and trained in the use of SPIN’s QVH, all provided at no additional cost to their existing practices.  Once the procedures are completed, SPIN will early monetize the affiliates case billing leaving no further collection risk. The new affiliate program capitalizes on SPIN’s unique position in having exclusive access to its patented QVH. When the decision was made in December to expand its affiliate program, the targets were to add a minimum of four affiliates, with two in Atlanta and maximum of 10 affiliates over the following year.  The company is pleased to report significant interest in the program by over 20 attendees, mostly from Atlanta, but also from four additional States making the high end of the target range appear very achievable. Additionally –though the QVH was originally developed for internal SPIN affiliate use, while under continuing development, it was  realized that a large additional market existed. A market for instantly transportable High Definition video providing transparency could be much broader.  For example, there is a need for  a Hybrid Video Integration Platform for general surgery, not only for QVH’s own four camera video showing internal x-ray real-time view along with three external cameras, but also to piggy-back additional video devices. QVH also has built-in capabilities to plug-in any digital or analog video medical device with “video out” capabilities. Devices used in robotic, arthroscopic, microscopic, etc. surgical procedures both for risk management, or use in hospitals and cadaver labs for global education can work with the QVH. Though direct sales were not the primary target at the Atlanta seminar, management also reports significant third party, non-PI interest, in the QVH such as described above from three attendees. Dr. Donovan stated; “On behalf of the SPIN and QVH Management, Directors and Development team, I cannot overstate how pleased we were with the reception we received from not just the attendees, but even the Sponsors and other Presenters at Atlanta. We anticipate adding and announcing new team members shortly. “ Donovan added; “For those not familiar with SPIN’s history, it should be noted that since inception some seven years ago, SPIN’s business advances to include the QVH development have been financed through its own organic revenues, sporadic third party straight debt paid off on time and some early loans by me later exchanged for shares. SPIN has never asked for, or received any outside equity financing, public or private. While I am the largest shareholder of the Company, the vast majority of my shares were either purchased in the open market or early loans I made to the Company which I converted to restricted shares at market value. The majority by far of my share purchases and/or debt conversions were at prices higher than the current share price.” We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons, DOs and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our management and financing services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases. Additional information about the company, along with a video can be found at its website at www.spineinjurysolutions.com. A wholly owned subsidiary of Spine Injury Solutions, Inc., Quad Video HALO, Inc brings surgeons and interventional pain management providers the ability to bring modern video documentation technology into the operating/treatment rooms. The Quad Video Technology™ V3.0 and HALO Rx™ creates a digital turnkey video and audio documentation solutions that integrates multiple views from other OR/treatment imaging sources with several other viewpoints just outside the sterile field. Additional information about QVH can be found at its website: www.quadvideohalo.com. Forward-Looking Statements: This press release includes forward-looking statements as determined by the U.S. Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical facts, included in this press release that address activities, events, or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations, healthcare services demands, changes in healthcare practices, government regulation, and other factors over which the company has little or no control. The company does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the warnings and cautionary statements contained in the company's recent filings with the SEC.


Spine Injury Solutions, Inc. (SPIN) unveils well-received Affiliate Expansion Program at seminar in Atlanta. After three years in development, SPIN’s patented Quad Video HALO™ (QVH) Video Medical Records Technology (VMRT), paired with its successful seven year history of injury case financing delivered through three contracted “Affiliates”, the stage has now been set for a nationwide expansion of its unique new Affiliate Program adding a high-tech advantage to injured accident victims. HOUSTON, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, finance,  and healthcare solution company servicing the multi-billion dollar spine injury sector, through its Chairman/CEO Dr. William Donovan, MD is pleased to report that the Company’s attendance and speaker participation at the pre-announced James J. Mathis “Personal Injury: Understanding Colossus Seminar” in Atlanta, GA, February 11, 2017 was a success in several aspects. The Seminar attendees, primarily made up of healthcare providers and attorneys servicing the  Personal Injury (PI) industry were introduced (most for the first time), to SPIN’s proprietary, patented, Quad Video HALO™ v3.0 and its success in facilitating patient confidence, “Best Medical Practices” and higher case settlements in shorter time for cases involving diagnostic and treatment injections. The original beta QVH first began clinic testing and trials in 2014 in Houston TX with Northshore Orthopedics (NSO), SPIN’s first “Affiliate” owned by SPIN Founder/Chairman. NSO along with several satellite locations, using SPIN’s Medical Lien financing program since 2010, had, up until the first use of QVH in 2014, financed over 6,000 diagnostic injection procedures in the conventional non-technical way similar to what the rest of the country uses today. While under continuing testing and development, the QVH received its US Patent in 2015 and its successful completion of compliance testing of the Quad Video HALO System to meet EN 60601-1 safety standard for medical equipment along with its EU approval to carry the CE Mark, in 2016. SPIN has internally invested approximately $2.5 million in developing the QVH which has now been used and proven successful in an additional 2,400 case procedures. Early on in the testing of the QVH, second and third SPIN Affiliates were added in Midland/Odessa and Tyler, TX who contributed to the latter 2,400 procedures. Armed with data and both medical and attorney testimonials giving clear “Proof of Concept” to the conjoining of the QVH v3.0 with conventional spine injection procedures, SPIN management made the decision in late 2016, to develop a new  Nationwide all-encompassing affiliate program to be introduced for the first time at the Atlanta seminar. New SPIN affiliates once qualified and accepted, will be trained to provide best practices, be referred cases generated by SPIN paid-for marketing, and trained in the use of SPIN’s QVH, all provided at no additional cost to their existing practices.  Once the procedures are completed, SPIN will early monetize the affiliates case billing leaving no further collection risk. The new affiliate program capitalizes on SPIN’s unique position in having exclusive access to its patented QVH. When the decision was made in December to expand its affiliate program, the targets were to add a minimum of four affiliates, with two in Atlanta and maximum of 10 affiliates over the following year.  The company is pleased to report significant interest in the program by over 20 attendees, mostly from Atlanta, but also from four additional States making the high end of the target range appear very achievable. Additionally –though the QVH was originally developed for internal SPIN affiliate use, while under continuing development, it was  realized that a large additional market existed. A market for instantly transportable High Definition video providing transparency could be much broader.  For example, there is a need for  a Hybrid Video Integration Platform for general surgery, not only for QVH’s own four camera video showing internal x-ray real-time view along with three external cameras, but also to piggy-back additional video devices. QVH also has built-in capabilities to plug-in any digital or analog video medical device with “video out” capabilities. Devices used in robotic, arthroscopic, microscopic, etc. surgical procedures both for risk management, or use in hospitals and cadaver labs for global education can work with the QVH. Though direct sales were not the primary target at the Atlanta seminar, management also reports significant third party, non-PI interest, in the QVH such as described above from three attendees. Dr. Donovan stated; “On behalf of the SPIN and QVH Management, Directors and Development team, I cannot overstate how pleased we were with the reception we received from not just the attendees, but even the Sponsors and other Presenters at Atlanta. We anticipate adding and announcing new team members shortly. “ Donovan added; “For those not familiar with SPIN’s history, it should be noted that since inception some seven years ago, SPIN’s business advances to include the QVH development have been financed through its own organic revenues, sporadic third party straight debt paid off on time and some early loans by me later exchanged for shares. SPIN has never asked for, or received any outside equity financing, public or private. While I am the largest shareholder of the Company, the vast majority of my shares were either purchased in the open market or early loans I made to the Company which I converted to restricted shares at market value. The majority by far of my share purchases and/or debt conversions were at prices higher than the current share price.” We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons, DOs and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our management and financing services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases. Additional information about the company, along with a video can be found at its website at www.spineinjurysolutions.com. A wholly owned subsidiary of Spine Injury Solutions, Inc., Quad Video HALO, Inc brings surgeons and interventional pain management providers the ability to bring modern video documentation technology into the operating/treatment rooms. The Quad Video Technology™ V3.0 and HALO Rx™ creates a digital turnkey video and audio documentation solutions that integrates multiple views from other OR/treatment imaging sources with several other viewpoints just outside the sterile field. Additional information about QVH can be found at its website: www.quadvideohalo.com. Forward-Looking Statements: This press release includes forward-looking statements as determined by the U.S. Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical facts, included in this press release that address activities, events, or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations, healthcare services demands, changes in healthcare practices, government regulation, and other factors over which the company has little or no control. The company does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the warnings and cautionary statements contained in the company's recent filings with the SEC.


News Article | March 1, 2017
Site: www.prweb.com

Even though automatic garage door openers do come with some amount of built-in surge protection, these parts are prone to gradual decomposition and need some sort of protection. One has to spend a few hundred dollars apart from installation charges if the automatic garage door opener has to be replaced. By adding surge protector installation to their laundry list of services, M.G.A. Garage Door Repair, a garage doors Houston based repair agency, recently made it easier for their users to save a lot on garage door repair. Garage door openers are often irreversibly damaged due to fluctuation in power supply or during thunderstorms. To prevent this, the garage door repair agency has started offering surge protector installation services. The co-founder of the company for garage door repair Houston claimed, “Utilizing surge shield at the opening from where the power reaches the opener is the most reasonable solution, but setting up entire home protection can guarantee all other sources of the garage power are protected against power spikes and the ensuing damage. When your expensive tools, freezers, refrigerators and laundry machines are plugged into wall outlets of a workshop in the garage then a spike in the power will not only damage the circuit boards but may also damage the appliances. In a garage which contains paint, fuel, and other combustible materials, the spark may result in a destructive house fire.” In order to protect garage doors against lightning as well as power fluctuations, the company now highly recommends having a surge protector installed on the garage door openers. A surge protector is designed distinctively to protect the openers of garage doors in Houston and comes with many features such as the door control panel, AC power line, as well as safety detectors. About the Company M.G.A Garage Door Repair Houston TX experts in garage door opener repair and maintenance now also provide surge protection to the doors. To know more about the company, visit http://garagedoors-houstontx.com/.


TROY, AL and FUQUAY VARINA, NC, February 25, 2017-- ABConsulting announced today two more small businesses that have been helped with seo services: Lillians Hair Works of Troy, Alabama and Crossfit Shoofly Gym in Fuquay Varina, North Carolina. ABConsulting has helped small business owners across the country, providing affordable web site editing, SEO work and other online marketing services."I enjoy giving small business owners a chance to compete with bigger companies," said Al Baker, Owner of ABConsulting. "The internet offers a way to level the playing field and I can help almost any small business gain new customers."New ABConsulting Customers:salon offers personal and friendly hair styling: haircuts, hair coloring and styling. Lillians serves all ages of women, young children, men and boys.is a licensed CrossFit gym in Fuquay Varina specializing in physical training for beginners as well as for elite athletes. All staff coaches have training in multiple aspects of exercise and fitness and are highly motivated to help others achieve their fitness goals.ABConsulting specializes in helping small businesses develop an integrated online marketing strategy using good web site content, affordable SEO (search engine optimization), pay-per-click advertising management, e-mail campaigns, social media, press releases, and a good web site customer funnel. ABConsulting has clients all over the USA including Baltimore MD, Houston TX, Durham and Raleigh NC and Seattle WA. Read more about ABConsulting: http://www.abconsulting-online.com/index.php?source=pr-2017-02


News Article | October 28, 2016
Site: www.prweb.com

Patriot Guard Riders traditionally escort fallen Veterans to their final resting place. In a historic shift on this somber tribute, the Patriot Guard embrace the opportunity to escort hyperbaric oxygen chambers as symbols for the new life they can bring to Veterans suffering from the ravages of traumatic brain injury – the invisible wound of war. The chambers are destined for Las Vegas, Nevada. Patriot Guards left Houston TX with the chambers to help spread the good news about the treatment that is not available to Veterans inside the VA. The veteran population faces a rising suicide rate and over 800,000 brain-wounded veterans and active duty service members are told there is no treatment that heals the wounds to their brains. Yet for over thirty years, HBOT has been responsible for thousands of successful interventions to help return the wounded to more normal lives denied them by VA reliance on addictive drugs and use of ineffective and unproven interventions. Sponsors include Chere Pederson, past President & Founding member of Blue Star Mothers in Southern Nevada; Las Vegas Veteran advocate Janet Franco, founder of the Pay it Forward Network International; and Barry Meuse, Air Force combat fighter pilot and Veteran advocate. They have combined to bring hyperbaric oxygen therapy to Las Vegas-area Veterans. HBOT is used tens of thousands of time daily helping athletes, first responders, police and firefighters and their families and is a game-changer in the fight against the epidemic of Veteran depression, homelessness and suicide caused by the scourge of untreated traumatic brain injury. Hyperbaric oxygen therapy (HBOT), widely used to treat a variety of injuries and diseases, has been shown to “permanently curtail TBI and PTSD symptoms, returning Veterans to a more normalized life” according to Dr. Paul Harch, perhaps the nation’s leading TBI and PTSD researcher and clinician. Dr. Harch published the first case of HBOT benefiting veterans with TBI and PTSD in 2009. Subsequently he and others worldwide published peer-reviewed confirmatory evidence that HBOT is safe and effective. Recent research from the Army offers preliminary proof of what medicine has been saying without proof for nearly 100 years -- blasts cause physical damage, and this physical damage leads to psychological problems, i.e., PTSD. The importance of this admission cannot be overstated: this is a DOD discovery with documented evidence that blast injury [IEDs, breeching, whether in training or combat, enemy and/or friendly fire] can lead directly to physical brain damage and the accompanying effects, many of which have been heretofore diagnosed as "only PTSD." The effects of the TBI/PTSD epidemic will linger for years if not confronted. The good news is that treatment with pressurized air has been shown to be effective for treating TBI/PTSD/PCS dating back decades. Vietnam Veterans and professional athletes wounded decades ago have been effectively treated and returned to near normal function. The planned Imagine N.O.W. Hyperbaric Treatment Center of Las Vegas will provide care to thousands of Las Vegas and Nevada Veterans who suffer daily from the devastating effects of TBI and PTSD. It will operate in cooperation with other Las Vegas and Nevada-based Veteran advocates such as the Blue Star Mothers, the Concerned Veterans of America, the Veteran Village of Las Vegas, the local chapter of the Disabled Veterans of America (DVA) and many others. The new Imagine NOW Center will treat Veterans under a research protocol to advance the science and include other supporting cognitive and physical therapies to raise cognitive skills as well as providing job-training opportunities to help Veterans treated at the Center return to the work place as productive citizens of the community.


News Article | February 15, 2017
Site: co.newswire.com

The best company in Houston TX is offering quality office equipment in the Houston and Woodlands, TX to ensure smooth business operation.

Loading Houston TX collaborators
Loading Houston TX collaborators